Moleculin Biotech (MBRX) Earnings Analysis
Moleculin Biotech (MBRX) has no confirmed upcoming earnings date. Last quarter (2026-05-14) it missed with EPS -3.54 USD vs -1.69 USD est (-109.5%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -0.07.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MBRX next report earnings?
No confirmed upcoming earnings date is currently scheduled for MBRX. This page updates as the calendar is published.
MBRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -3.54 USD | -1.69 USD | -109.5% | Miss |
| 2026-03-20 | 2.61 USD | -7.77 USD | +133.6% | Beat |
| 2025-11-13 | -3.25 USD | -5 USD | +35% | Beat |
| 2025-03-21 | -0.37 USD | -1.54 USD | +76% | Beat |
| 2024-11-11 | -2.85 USD | -2.44 USD | -16.8% | Miss |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
MBRX valuation and analyst view
| Trailing P/E | -0.07 |
|---|---|
| Trailing EPS | -7.35414 USD |
| Price / book | 0.57 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (4 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Moleculin Biotech (MBRX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for MBRX. This page updates as the calendar is published.
Did MBRX beat earnings last quarter?
In its 2026-05-14 report, MBRX posted EPS of -3.54 USD versus a -1.69 USD estimate — a miss of 109.5%.
What is MBRX's earnings track record?
Over the last 5 reported quarters with consensus data, MBRX beat estimates 3 times (60%).
What is MBRX's current P/E ratio and EPS?
MBRX trades at a trailing P/E of -0.07 on trailing EPS of -7.354135622364215 USD.
What do analysts rate MBRX?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell).